| Publications | PubMed=1785673; DOI=10.1097/00043426-199124000-00011
Ursula R. Kees, Marie T. Mulcahy, Michael Lawrence Nesbit Willoughby;
Intrathoracic carcinoma in an 11-year-old girl showing a translocation t(15;19).
Am. J. Pediatr. Hematol. Oncol. 13:459-464(1991) PubMed=17934517; DOI=10.1038/sj.onc.1210852
Christopher Alexander French, Cherie L. Ramirez, Julia Kolmakova, Tyler T. Hickman, Michael J. Cameron, M.E. Thyne, Jeffery L. Kutok, Jeffrey A. Toretsky, A.K. Tadavarthy, Ursula R. Kees, Jonathan A. Fletcher, Jon Christopher Aster;
BRD-NUT oncoproteins: a family of closely related nuclear proteins that block epithelial differentiation and maintain the growth of carcinoma cells.
Oncogene 27:2237-2242(2008) PubMed=21447744; DOI=10.1158/0008-5472.CAN-10-3513; PMCID=PMC3070805
Brian E. Schwartz, Matthias D. Hofer, Madeleine E. Lemieux, Daniel Evan Bauer, Michael J. Cameron, Nathan H. West, Elin S. Agoston, Nicolas Reynoird, Saadi Khochbin, Tan A. Ince, Amanda L. Christie ...Show all 19 authors... , Katherine A. Janeway, Sara Oakes Vargas, Antonio Rafael Perez-Atayde, Jon Christopher Aster, Stephen Earl Sallan, Andrew L. Kung, James E. Bradner, Christopher Alexander French; Show fewer authors
Differentiation of NUT midline carcinoma by epigenomic reprogramming.
Cancer Res. 71:2686-2696(2011) PubMed=23128391; DOI=10.1038/onc.2012.487
Katherine Thompson-Wicking, Richard W. Francis, Anja Stirnweiss, Emanuela Ferrari, Mat D. Welch, Elizabeth G. Baker, Ashleigh R. Murch, Alexander M. Gout, Kim Warwick Carter, Adrian K. Charles, Marianne B. Phillips ...Show all 13 authors... , Ursula R. Kees, Alex H. Beesley; Show fewer authors
Novel BRD4-NUT fusion isoforms increase the pathogenic complexity in NUT midline carcinoma.
Oncogene 32:4664-4674(2013) PubMed=24518598; DOI=10.1038/bjc.2014.54; PMCID=PMC3950881
Alex H. Beesley, Anja Stirnweiss, Emanuela Ferrari, Raelene Endersby, Meegan Howlett, Timothy W. Failes, Greg M. Arndt, Adrian K. Charles, Catherine Helen Cole, Ursula R. Kees;
Comparative drug screening in NUT midline carcinoma.
Br. J. Cancer 110:1189-1198(2014) PubMed=29348827; DOI=10.18632/oncotarget.22862; PMCID=PMC5762512
Anja Stirnweiss, Joyce Oommen, Rishi S. Kotecha, Ursula R. Kees, Alex H. Beesley;
Molecular-genetic profiling and high-throughput in vitro drug screening in NUT midline carcinoma-an aggressive and fatal disease.
Oncotarget 8:112313-112329(2017) |
|---|
